Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
Hong Kong · Delayed Price · Currency is HKD 5.47
0.00 (0.00%)
Jun 3, 2026, 3:47 PM HKT
Charmacy Pharmaceutical Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 591 | 787 | 1,058 | 1,400 | 744 | 603 | |
Market Cap Growth | -29.42% | -25.61% | -24.38% | 88.10% | 23.48% | 2.57% |
Enterprise Value | 1,784 | 1,537 | 1,681 | 1,659 | 1,548 | 1,675 |
Last Close Price | 5.47 | 6.86 | 8.64 | 11.15 | 5.57 | 4.51 |
PE Ratio | 11.47 | 15.29 | 18.67 | 24.75 | 7.28 | 21.21 |
Forward PE | - | 13.45 | 13.45 | 13.45 | 13.45 | 13.45 |
PS Ratio | 0.12 | 0.16 | 0.22 | 0.29 | 0.16 | 0.13 |
PB Ratio | 0.86 | 1.15 | 1.61 | 2.13 | 1.11 | 0.97 |
P/TBV Ratio | 0.98 | 1.31 | 1.84 | 2.47 | 1.30 | 1.38 |
P/FCF Ratio | 2.02 | 2.69 | 11.01 | - | 18.56 | - |
P/OCF Ratio | 1.96 | 2.61 | 9.38 | - | 14.94 | - |
EV/Sales Ratio | 0.37 | 0.32 | 0.36 | 0.34 | 0.33 | 0.36 |
EV/EBITDA Ratio | 9.96 | 9.08 | 9.43 | 11.59 | 11.32 | 13.18 |
EV/EBIT Ratio | 12.19 | 10.50 | 11.68 | 13.91 | 14.65 | 18.33 |
EV/FCF Ratio | 6.09 | 5.24 | 17.50 | - | 38.62 | - |
Debt / Equity Ratio | 2.98 | 2.98 | 2.28 | 2.30 | 1.99 | 2.63 |
Debt / EBITDA Ratio | 11.41 | 11.41 | 8.42 | 10.20 | 9.55 | 12.47 |
Debt / FCF Ratio | 6.98 | 6.98 | 15.61 | - | 33.43 | - |
Net Debt / Equity Ratio | 1.74 | 1.74 | 1.35 | 1.22 | 1.15 | 1.36 |
Net Debt / EBITDA Ratio | 7.05 | 7.05 | 4.99 | 5.62 | 5.63 | 6.62 |
Net Debt / FCF Ratio | 4.07 | 4.07 | 9.25 | -5.31 | 19.22 | -15.37 |
Asset Turnover | 1.18 | 1.18 | 1.32 | 1.44 | 1.48 | 1.36 |
Inventory Turnover | 5.58 | 5.58 | 5.75 | 6.04 | 7.13 | 6.51 |
Quick Ratio | 0.63 | 0.63 | 0.66 | 0.63 | 0.66 | 0.66 |
Current Ratio | 1.09 | 1.09 | 1.09 | 1.07 | 1.09 | 1.04 |
Return on Equity (ROE) | 7.49% | 7.49% | 8.76% | 8.61% | 16.46% | 4.60% |
Return on Assets (ROA) | 2.22% | 2.22% | 2.52% | 2.21% | 2.08% | 1.67% |
Return on Invested Capital (ROIC) | 5.60% | 6.02% | 7.28% | 6.33% | 5.62% | 4.46% |
Return on Capital Employed (ROCE) | 19.40% | 19.40% | 20.30% | 17.20% | 15.30% | 12.30% |
Earnings Yield | 8.72% | 6.54% | 5.36% | 4.04% | 13.74% | 4.72% |
FCF Yield | 49.62% | 37.23% | 9.08% | -10.81% | 5.39% | -9.08% |
Dividend Yield | 6.34% | 4.87% | 5.54% | 2.96% | 9.14% | - |
Payout Ratio | 173.97% | 173.97% | 120.49% | 147.05% | 31.44% | 226.73% |
Buyback Yield / Dilution | 0.01% | 0.01% | 0.01% | -0.00% | -0.01% | 0.01% |
Total Shareholder Return | 6.35% | 4.87% | 5.55% | 2.96% | 9.13% | 0.01% |